CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising patient population and awareness about umbilical stem cells
4.1.2. Growing number of hematopoietic stem cell transplantation procedures
4.1.3. Growing investments in stem cell-based research
4.1.4. Technological advancements of stem cell preservation, processing, and storage
4.1.5. Rising R&D initiatives to develop therapeutic options for chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Expensive procedures
4.2.2. Regulatory complications
4.2.3. Socio-ethical concerns related to embryonic stem cells
4.3. Market Opportunities
4.3.1. Rising global burden of major diseases
4.3.2. Emerging countries
CHAPTER 5. GLOBAL STEM CELL BANKING MARKET – BY SOURCE
5.1. Placental Stem Cells
5.2. Adipose Tissue-Derived Stem Cells
5.3. Bone Marrow-Derived Stem Cells
5.4. Human Embryo-Derived Stem Cells
5.5. Dental Pulp-Derived Stem Cells
5.6. Others
CHAPTER 6. GLOBAL STEM CELL BANKING MARKET – BY SERVICE TYPE
6.1. Sample Preservation and Storage
6.2. Sample Analysis
6.3. Sample Processing
6.4. Sample Collection and Transportation
CHAPTER 7. GLOBAL STEM CELL BANKING MARKET – BY APPLICATION
7.1. Personalized Banking Applications
7.2. Research Applications
7.2.1. Disease Treatment Studies
7.2.2. Life Science Research
7.2.3. Drug Discovery
7.3. Clinical Applications
7.3.1. Hematopoietic Disorders
7.3.2. Autoimmune Disorders
7.3.3. Others
CHAPTER 8. GLOBAL STEM CELL BANKING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL STEM CELL BANKING MARKET - COMPANY PROFILES
9.1. Cord Vida
9.2. StemCyte India Pvt Ltd
9.3. ViaCord
9.4. Global Cord Blood Corporation
9.5. Smart Cells International Ltd
9.6. Vita34 AG
9.7. CryoHoldco S.A.P.I
9.8. Cord Blood Registry Systems
9.9. Cordlife, Inc.
9.10. Cryo-Cell International, Inc.
9.11. Cryo-Save AG
9.12. Life Cell International Pvt. Ltd
CHAPTER 10. GLOBAL STEM CELL BANKING MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
